Constitutively dead, conditionally live HIV-1 genomes. Ex vivo implications for a live virus vaccine (Q40800305)

23 September 2017

title

Constitutively dead, conditionally live HIV-1 genomes. Ex vivo implications for a live virus vaccine (English)

1 reference

23 September 2017

Smith SM

1 reference

23 September 2017

Khoroshev M

1 reference

23 September 2017

Marx PA

1 reference

23 September 2017

Orenstein J

1 reference

23 September 2017

Jeang KT

1 reference

23 September 2017

language of work or name

English

0 references

publication date

7 June 2001

1 reference

Journal of Biological Chemistry

23 September 2017

published in

1 reference

23 September 2017

volume

276

1 reference

23 September 2017

1 reference

23 September 2017

page(s)

32184-32190

1 reference

Macaque models for AIDS vaccine development

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

Conditional reduction of human immunodeficiency virus type 1 replication by a gain-of-herpes simplex virus 1 thymidine kinase function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

A candidate live inactivatable attenuated vaccine for AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

Transcriptional activation by tetracyclines in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

Multifaceted activities of the HIV-1 transactivator of transcription, Tat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

Tat trans-activates the human immunodeficiency virus through a nascent RNA target

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

The effect of template RNA structure on elongation by HIV-1 reverse transcriptase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

T cell receptor-MHC interactions up close

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

Biological considerations in the development of a human immunodeficiency virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

Replication rate and evolution in the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

Deletion mutagenesis downstream of the 5' long terminal repeat of human immunodeficiency virus type 1 is compensated for by point mutations in both the U5 region and gag gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

Leader sequences downstream of the primer binding site are important for efficient replication of simian immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

Potent and stable attenuation of live-HIV-1 by gain of a proteolysis-resistant inhibitor of NF-kappaB (IkappaB-alphaS32/36A) and the implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M101604200

21 January 2018

Identifiers

DOI

10.1074/JBC.M101604200

1 reference

23 September 2017

1 reference